Chen-Yuan Lin

1 article listing Chen-Yuan Lin in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanced/metastatic esophageal squamous cell carcinoma: minimum 3-year survival follow-up of a randomized phase 3 trial (RATIONALE-306) Nature Communications